EMA gives green light to another adapted COVID-19 vaccine for Omicron, another key step says Kyriakides

The European Medicines Agency (EMA) has given its positive opinion for the approval of another booster vaccine adapted by BioNTech-Pfizer (Comirnaty) to deal with the BA.4 and BA.5 subvariants of the Omicron variant of SARS-CoV-2, the virus that causes COVID-19.